Price $33.99 |
Market Cap
207.07B
|
Sector Health Care |
Div. Growth
2.50%
|
|
P/E
7.2
|
P/B
2.05
|
P/S
2.22
|
Dividend %
4.50%
|
|
P/CF
-
|
P/FCF
18.8
|
Op. Cash Flow
23.94M
|
FCF
1.9
|
|
Op. Margin
35.80%
|
Net Margin
31.30%
|
ROE
30.90%
|
ROI
25.30%
|
|
ROA
14.80%
|
EPS Growth
16.40%
|
Current Ratio
1.2
|
Debt/Equity
34.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.82 | - | - | 3.1M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $22.55 | - | - | 743.4M | Strong Buy |
| Precipio Inc (PRPO) | $0.32 | - | - | 10.7M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $1.53 | - | - | 92.3M | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.01 | - | - | 5.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
